TAT-N24 is a cell-permeable TAT peptide as a p55PIK signaling inhibitor. TAT-N24 is effective for corneal neovascularization (CNV) and ocular inflammation by inhibiting the HIF-1alpha/NF-kappaB signaling pathway in corneal suture (CS). TAT-N24 also inhibits corneal neovascularization[1].
